Equibles does not estimate personal net worth.
Get an email with a short summary when Evolent Health, Inc. publishes a filing, an earnings call transcript or a press release.
Get EVH alertsMario Ramos is recorded as CFO at Evolent Health, Inc. (EVH) and CFO at Evolv Technologies Holdings, Inc. (EVLV) since November 1, 2021. Evolent Health, Inc. reported in an 8-K filed November 6, 2025 that Mario Ramos was appointed Chief Financial Officer, effective January 1, 2026. The proxy statement of Evolv Technologies Holdings, Inc. reports total compensation of $4,466,153 for Mario Ramos in fiscal 2021, including a base salary of $66,154. Mario Ramos has spoken on 7 earnings calls across 2 companies, most recently for Evolent Health, Inc. on November 5, 2026. Those appearances were for Evolent Health, Inc. (EVH) and Evolv Technologies Holdings, Inc. (EVLV). Evolent Health, Inc. is classified in the Health Information Services industry within the Healthcare sector. Evolv Technologies Holdings, Inc. is classified in the Security & Protection Services industry within the Industrials sector. Other leadership on record at Evolent Health, Inc. includes Frank Williams (Chairman and Board Member), Mr. Williams (Chairman), Richard "Rick" Jelinek (Chairman) and 7 others.
“On November 6, 2025, the Board of Directors (the "Board") of the Company appointed Mario Ramos, 54, as the Company's Chief Financial Officer (principal financial officer), effective January 1, 2026 (the "Effective Date").”
“Our third quarter results reflect continued growth in the performance suite and strong MER performance. Total revenue was $725 million, up approximately 11% versus the second quarter.”
“We delivered solid second quarter financial results that were above our expectations and the outlook we discussed on the Q1-2026 call in May. Total revenue was $653 million, up 31% versus Q1-2026, and adjusted EBITDA was $28 million, up 27% quarter over quarter.”
“We delivered solid first quarter financial results that were in line with our expectations and consistent with the outlook we discussed on the Q4 call in February.”
“I'm excited to be here and energized by the opportunity ahead. Let me begin with Q4 2025 financial performance. Q4 revenue totaled $469 million and adjusted EBITDA was $37.8 million, which exceeded the midpoint of guidance.”
“I'm going to review our first quarter results in more detail, and then share some thoughts on how we're thinking about the rest of the year. We ended the first quarter with 910 active subscriptions, up 29% sequentially and 227% year-over-year.”
2021-11-01–present
2021-11-01–present
Start not stated–2022-05-31
Health Information Services · Healthcare
CFO
Security & Protection Services · Industrials
CFO
2021-11-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Evolv Technologies Holdings, Inc. (EVLV) | Chief Financial Officer and Chief Risk Officer | $66,154 | $4,466,153 |
